NCT00695097View on ClinicalTrials.gov

The Effect of Rituximab on the Development of Anti-Donor Antibodies

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Renal Transplant Rejection
Interventions
DRUG

Rituximab

Rituximab infusion on Day 1 and Day 15

DRUG

No Rituximab

No Rituximab

Trial Locations (2)

35294

University of Alabama at Birmingham, Birmingham

94143

UCSF-Kidney Transplant Clinic, San Francisco

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of California, San Francisco

OTHER